Home › Funds › Omega Fund Management, LLC › BCAX

Omega Fund Management, LLC position in BCAX

BICARA THERAPEUTICS INC · Health Care

Omega Fund Management, LLC reported holding 1,822,150 shares of BCAX (BICARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$54.1M, representing 29.14% of its reported portfolio and ranking #1 among its reported holdings. Omega Fund Management, LLC has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.82M sh
Reported value held$54.10M
Portfolio Weight29.14%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Omega Fund Management, LLC's BCAX position evolved

Omega Fund Management, LLC first disclosed a stake in BCAX in Q3 2024 at 2,204,650 shares (US$56.2M). Across 8 filings, Omega Fund Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,822,150 shares valued at US$54.1M — a reduction of -570,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.20M $56.15M New
Q4 2024 2.20M $38.41M Hold
Q1 2025 2.20M $28.73M Hold
Q2 2025 2.20M $20.48M Hold
Q3 2025 2.20M $34.81M Hold
Q4 2025 2.20M $37.10M Hold
Q1 2026 2.39M $47.58M Add
Q2 2026 1.82M $54.10M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Siren, L.L.C. (US$166.4M), Vestal Point Capital, LP (US$155.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has Omega Fund Management, LLC held BCAX?

Omega Fund Management, LLC has disclosed BCAX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Omega Fund Management, LLC's current position in BCAX?

As of Q2 2026, Omega Fund Management, LLC holds 1.82M shares of BCAX (BICARA THERAPEUTICS INC), valued at $54.10M, representing 29.14% of its reported portfolio and ranking #1.

Has Omega Fund Management, LLC been buying or selling BCAX?

In the latest 13F filing (Q2 2026), Omega Fund Management, LLC reduced its position in BCAX.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.